NYSE · Healthcare
Hims & Hers Health, Inc. (HIMS)
As-reported financials and recent SEC filings for Hims & Hers Health, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.35B
Net income
$128.4M
Net margin
5.5%
Diluted EPS
$0.51
ROE
23.7%
P/E (TTM)
66.5×
Market cap
$7.86B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.0M | $526.9M | $271.9M |
| Gross profit | $1.73B | $1.17B | $714.9M | $408.7M | $204.5M |
| Operating income | $105.6M | $61.9M | $-29.5M | $-68.7M | $-115.0M |
| Net income | $128.4M | $126.0M | $-23.5M | $-65.7M | $-107.7M |
| Diluted EPS | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-23
View on EDGAR →42026-06-23
View on EDGAR →1442026-06-18
View on EDGAR →1442026-06-17
View on EDGAR →1442026-06-17
View on EDGAR →1442026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →Go deeper on HIMS
Search Hims & Hers Health, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.